Phototoxicity – from molecular descriptors to classification models


Potential photoactivation of certain pharmaceuticals, cosmetic ingredients and natural products by sunlight (e.g., phenothiazines, arylsulfonamides, or coumarins) has to be considered early on in development in order to avoid serious adverse effects (for example phototoxic or photoallergic reactions). Current clinical trial registration guidelines (FDA May… (More)
DOI: 10.1186/1758-2946-3-S1-O10


  • Presentations referencing similar topics